BBIO Historical PE Ratio image   This BBIO PE ratio history page last updated 5/9/2022
BBIO PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2022
5/5/2022
7.51-1.19-3.92NA
Q4 2021
2/24/2022
8.00-1.01-3.91NA
Q3 2021
11/4/2021
51.46-1.06-3.91NA
Q2 2021
8/5/2021
56.13-0.66-3.83NA
Q1 2021
5/6/2021
49.59-1.18-4.20NA
Q4 2020
2/25/2021
65.13-1.01-3.80NA
Q3 2020
11/5/2020
40.99-0.98-3.41NA
Q2 2020
8/11/2020
28.39-1.03-2.94NA
Q1 2020
5/13/2020
30.78-0.78-5.37NA
Q4 2019
3/2/2020
32.21-0.62NANA
Q3 2019
11/7/2019
24.42-0.51NANA
Q2 2019
8/14/2019
25.89-3.46NANA
BBIO Historical PE Ratio Chart
Data adjusted for BBIO split history

PeriodPriceAdj. EPSAnnualizedPE
Q1 2022
5/5/2022
7.51-1.19-4.76NA
Q4 2021
2/24/2022
8.00-1.01-4.04NA
Q3 2021
11/4/2021
51.46-1.06-4.24NA
Q2 2021
8/5/2021
56.13-0.66-2.64NA
Q1 2021
5/6/2021
49.59-1.18-4.72NA
Q4 2020
2/25/2021
65.13-1.01-4.04NA
Q3 2020
11/5/2020
40.99-0.98-3.92NA
Q2 2020
8/11/2020
28.39-1.03-4.12NA
Q1 2020
5/13/2020
30.78-0.78-3.12NA
Q4 2019
3/2/2020
32.21-0.62-2.48NA
Q3 2019
11/7/2019
24.42-0.51-2.04NA
Q2 2019
8/14/2019
25.89-3.46-13.84NA
Quotes delayed 20 minutes

Email EnvelopeFree BBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
BridgeBio Pharma (BBIO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BBLG PE Ratio History
BCAB PE Ratio History
BCDA PE Ratio History
BCEL PE Ratio History
BCLI PE Ratio History
BCRX PE Ratio History
BDSI PE Ratio History
BDSX PE Ratio History
BDTX PE Ratio History
BDX PE Ratio History
On this page we presented the BBIO PE Ratio History information for BridgeBio Pharma' stock. The average BBIO PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BBIO PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BBIO PE ratio history result, against the recent PE: when this page was posted on 5/6/2022, the most recent closing price for BBIO had been 6.70, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on BBIO or any other given stock, valuation analysis for BBIO can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate BridgeBio Pharma PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for BBIO. Thanks for visiting, and the next time you need to research BBIO PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: NFTY Average Annual Return, TTF Historical Stock Prices, Top Ten Hedge Funds Holding SBCF.

 

BBIO PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.